Guest faints at White House event
By South China Morning Post
This transcript is extremely short and appears to be an incomplete snippet from a YouTube video. It contains very little substantive information to summarize.
Key Concepts:
- Eli Lilly (company)
- Investment in America
- Advancing science
- Creating high-value jobs
- "We're done." (statement of cessation)
Summary:
The speaker, representing the company Eli Lilly, states that for nearly 150 years, the company has been investing in America, advancing science, and creating high-value jobs. However, the speaker then declares, "But today we you okay Gordon? You okay? Yeah. Thank you. Cameas we're done." This statement, followed by music, suggests a cessation or ending of these activities. The interjection "Oh, are you okay, Gordon? You okay?" indicates a brief, possibly unexpected, interruption or concern for an individual named Gordon.
Main Topics and Key Points:
- Eli Lilly's Historical Commitment: For approximately 150 years, Eli Lilly has been a significant investor in the United States.
- Core Activities: The company's primary contributions have been in advancing scientific research and development, and in generating high-value employment opportunities.
- Abrupt End: The statement "we're done" signifies a definitive halt to these previously established activities.
Notable Quotes:
- "For nearly 150 years, uh, my company, Eli Liy, has been investing in America. We've been advancing science and creating high-v valueue jobs." - Speaker (representing Eli Lilly)
- "But today we you okay Gordon? You okay? Yeah. Thank you. Cameas we're done." - Speaker (representing Eli Lilly)
Conclusion:
The transcript conveys a stark message of Eli Lilly ending its long-standing investments, scientific advancements, and job creation in America. The reason for this abrupt cessation is not provided within this snippet.
Chat with this Video
AI-PoweredLoad the transcript when you're ready to chat so the initial page stays lighter.
Related Videos

The Open for Friday, June 26, 2026
BNN Bloomberg

'SHOW OF CONFIDENCE': J&J unveils MAJOR US manufacturing investment
Fox Business

'A lot of opportunity in the conventional generics': Apotex CEO on rise of interest in generics
BNN Bloomberg

Apotex raised $1.3 billion in its IPO
BNN Bloomberg

Pharmaceutical industry becomes geopolitical battleground as US threatens tariffs • FRANCE 24
FRANCE 24 English

Morning Markets for Friday, May 1, 2026
BNN Bloomberg

AstraZeneca shares drop after vote against breast cancer drug
Reuters